Ophthalmologic Care with Mydriatic Agents

Introduction to Mydriatic Agents

Mydriatic agents, such as cyclopentolate, can cause visual hallucinations with durations varying from 6-24 hours, and have a higher potential for CNS effects, including hallucinations, as noted by the American Academy of Ophthalmology 1
The use of mydriatic agents can lead to visual hallucinations, with effects comparable to GHB-like reactions lasting 3-6 hours without alcohol and 36-72 hours with alcohol or other drugs 2

Certain populations, including young children, infants, elderly patients, patients with Down syndrome, individuals with brain damage or neurological conditions, patients with spastic paralysis, and those with vision impairment, are more vulnerable to experiencing visual hallucinations after pupil dilation, as related to the effects of cyclopentolate 1
Patients with vision impairment are at risk of Charles Bonnet Syndrome (CBS), characterized by recurrent, vivid visual hallucinations, with a prevalence ranging from 15-60% in patients with ophthalmologic disorders, as recognized by the American Academy of Ophthalmology 3

Visual hallucinations from mydriatic agents can present as simple hallucinations (lights, streaks, flashes), complex hallucinations (objects, people, scenes), or visual distortions (blurred vision, light sensitivity), with effects comparable to ketamine-like reactions occurring within 20 minutes and lasting less than 3 hours 2
The American Academy of Ophthalmology guidelines recognize several visual phenomena that can occur after dilation, including simple visual hallucinations, blurred vision, light sensitivity, visual distortions, and in severe cases, more complex hallucinations 3

The American Academy of Ophthalmology recommends using topical anesthetic prior to dilation to reduce stinging and improve penetration, which can help reduce the risk of hallucinations and other systemic side effects 1
Ocular occlusion of the lacrimal punctum can be useful in reducing systemic side effects, as recommended by the American Academy of Ophthalmology 1, 4
Patients should be educated about potential side effects and reassured if hallucinations occur, with monitoring of vulnerable patients recommended for at least 30 minutes after administration, as per the American Academy of Ophthalmology guidelines 3

Patients should seek immediate medical care if experiencing hallucinations accompanied by confusion or disorientation, severe behavioral changes, hallucinations that persist long after dilation effects should have worn off, or hallucinations with atypical features, as per the American Academy of Ophthalmology guidelines 3
In cases of severe anticholinergic toxicity requiring emergency care, physostigmine may be administered, as noted by the American Academy of Ophthalmology, with the strength of evidence for this fact being based on expert opinion and clinical experience 1

Pupillary dilation is strongly recommended for optimal examination of structures posterior to the iris, including the optic nerve, macula, and peripheral retina, as it allows better visualization of the posterior segment structures, provides access to the peripheral retina, and improves the quality of fundus examination, according to the American Academy of Ophthalmology 5, 6
For routine ophthalmoscopy in adults, tropicamide 1% (one or two drops) may be used, and may be combined with phenylephrine 2.5% for more effective dilation, as stated by the American Academy of Ophthalmology 7
For children over 12 months, cyclopentolate 1% is recommended for pupillary dilation, while for children under 6 months, cyclopentolate 0.2% with phenylephrine 1% is recommended, according to the American Academy of Pediatrics and the American Academy of Ophthalmology 4
The dose of cyclopentolate 1% for patients over 12 months should be determined based on weight, iris color, and history of dilation, as per the American Academy of Pediatrics and the American Academy of Ophthalmology 1, 4

Patients with suspected narrow angles require caution when dilating, and pupil dilation should be done with caution, with cautious dilation with low-strength tropicamide if deemed essential, as advised by the American Academy of Ophthalmology 8
Patients with suspected occludable angles should be warned about signs and symptoms until an iridotomy has been performed, and cautious dilation with low-strength tropicamide can be performed if dilation is deemed essential, according to the American Academy of Ophthalmology 8
Dilation should be performed with caution in patients with suspected angle-closure glaucoma, as advised by the American Academy of Ophthalmology 9
If dilation is contraindicated or not feasible, alternative methods such as direct ophthalmoscope, slit-lamp biomicroscope with indirect lens through undilated pupil, nonmydriatic fundus photography, or optical coherence tomography may be considered, as stated by the American Academy of Ophthalmology 9

Patients should be informed that their vision may be temporarily blurred, they may experience light sensitivity, and driving ability may be impaired after dilation, with complete recovery taking several hours 9
Topical anesthetic prior to dilation can reduce stinging and improve penetration of mydriatics, as recommended by the American Academy of Ophthalmology 1, 4
Inadequate dilation can limit visualization, particularly in patients with dark irides, and systemic side effects such as fever, dry mouth, tachycardia, nausea, vomiting, and somnolence can occur, especially in children and elderly patients, as reported by the American Academy of Ophthalmology 1, 4